Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

infectious · Mechanism Report

Do Anaplasma IgM and IgG reflect recent immune recognition, while a negative blood PCR only means DNA was not detected in that specimen?

Anaplasma IgM and IgG can indicate recent immune recognition, and a negative blood PCR does not by itself exclude ongoing bloodstream infection.

PlausibleSeptember 23, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Anaplasma-specific IgM and IgG can reflect recent immune recognition, while a negative blood PCR means Anaplasma DNA was not detected in that specimen and does not prove ongoing bloodstream infection.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says serology and PCR answer different questions: antibodies reflect the host immune response over time, while PCR looks for detectable pathogen DNA in one blood specimen. The graph frames IgG rise or seroconversion as the clearest sign of recent recognition, and it treats a negative PCR as a nondetection result that cannot prove clearance or absence of infection.

Verified conclusion

The claim is supported: antibody testing and blood PCR answer different clinical questions and must be interpreted in time-specific context.

Serologic evidence

  • Anaplasma-specific IgG seroconversion or a ≥4-fold rise in paired IFA titers between acute (first 2 illness weeks) and convalescent (2–10 weeks later) samples is established evidence of recent immune recognition.
  • A single IgG result is only supportive: IgG may be absent early, then persist for 12–18 months and occasionally 3–4 years after infection. Persistent IgG does not demonstrate active infection or treatment failure.
  • IgM may appear early but has limited specificity and may persist; it should not independently establish recent anaplasmosis. Antibodies can also cross-react between Anaplasma and Ehrlichia, limiting species-specific interpretation.

Molecular testing and clinical meaning

  • A negative whole-blood PCR precisely means that the assay did not detect its Anaplasma DNA target in that submitted specimen. It does not mean “no anaplasmosis” or prove microbiologic clearance.
  • Whole-blood PCR is most sensitive during the first illness week (reported sensitivity roughly 70–100%), but sensitivity declines later and may fall below 50%. In one multicenter evaluation, PCR sensitivity was 74% despite 100% specificity.
  • Because Anaplasma is cell-associated, low circulating burden, timing, and specimen/preanalytic factors can yield nondetection. Doxycycline or tetracycline can reduce PCR sensitivity within approximately 48 hours.

Mechanistic and practical implications

  • Serology reflects the host immune response, which can outlast infection; PCR reflects detectable circulating pathogen DNA at one moment. Neither isolated antibody positivity nor PCR negativity alone establishes whether viable organisms remain in blood.
  • When illness and exposure history remain compatible, CDC guidance supports not withholding or stopping doxycycline solely because PCR is negative; paired serology can later substantiate recent infection.

Bottom line

  • IgM/IgG can indicate recent immune recognition—most convincingly by paired IgG change—while a negative blood PCR is only specimen-level DNA nondetection and cannot exclude ongoing bloodstream infection, particularly late in illness or after antibiotics.

References

  1. A review on the eco-epidemiology and clinical management of ... — link.springer.com ↗
  2. Human Granulocytic Anaplasmosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  3. Clinical Testing and Diagnosis for Anaplasmosis - CDC — cdc.gov ↗
  4. Anaplasma – PCR and Serology | Public Health Ontario — publichealthontario.ca ↗
  5. Value of PCR, Serology, and Blood Smears for Human ... — stacks.cdc.gov ↗
  6. Comparison of a Real-Time PCR Method with Serology and Blood Smear Analysis for Diagnosis of Human Anaplasmosis: Importance of Infection Time Course for Optimal Test Utilization | Journal of Clinical Microbiology — journals.asm.org ↗
  7. <em>Anaplasma phagocytophilum</em> Antibodies in Humans, Japan, 2010–2011 — wwwnc.cdc.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes a negative blood PCR rule out Lyme borreliosis?→Plausible5 sourcesDoes a negative blood PCR or positive antibody test rule out or confirm active Borrelia infection?→